Pathol Biol (Paris). 2009 Nov-Dec;57(7-8):555-9. Epub 2009 Oct 31
Germain D.
Université Claude-Bernard Lyon-I, 8, avenue Rockefeller, 69008 Lyon, France. [email protected]
Abstract
There is less than three years, the reprogramming of adult cells in induced pluripotent stem cells (iPS cells) has been added to the techniques producing natural or manufactured embryonic cells. Easier to obtain than these last, the human iPS cells are ethically irreproachable. They allow the study of many disorders at the cellular level and put at the disposal of pharmacologists a material of an exceptional interest. The improvement of the quality of their reprogramming is the object of active search all over the world. It is not utopian to hope that the iPS cells will quickly take a choice place in human cellular therapy.
PMID: 19880264 [PubMed – indexed for MEDLINE]
